Placenta Previa et Percreta: A Potentially Life-Threatening Condition.
caesarean section
diagnosis
imaging
life-threatening condition
percreta
placenta accreta spectrum
placenta previa
pregnancy
scar infiltration
ultrasound
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
01 Feb 2023
01 Feb 2023
Historique:
received:
26
12
2022
accepted:
31
01
2023
entrez:
11
2
2023
pubmed:
12
2
2023
medline:
12
2
2023
Statut:
epublish
Résumé
Placenta percreta occurs in about 5% of placenta accreta spectrum (PAS) and causes high maternal and fetal peripartum morbidity/mortality. A 34-year-old multiparous 4G2P (1xcesarean section (CS)) was admitted to hospital at the 34th week of gestation. Transvaginal ultrasound revealed a placenta previa totalis et percreta with a small tissue layer towards the bladder. Ultrasound was crucial for further planning. An interdisciplinary setting was established based on this life-threatening diagnosis. Due to the onset of labor one day later, a CS was performed. Intraoperatively, the suspicion was confirmed of a placenta previa et percreta with CS scar infiltration. Due to the life-threatening bleeding risk, simultaneous subtotal hysterectomy was needed. The diagnosis was confirmed histologically. The higher the number of previous CS, the higher the PASrate. Placenta percreta is the most severe form of this, characterized by placental invasion through the entirety of the myometrium and possibly into extrauterine tissues. This case demonstrates the great importance of prenatal diagnosis with the realization of dimensions of this very rare finding, especially with an increasing CS rate and other associated complications. Due to the close interdisciplinary cooperation of the prenatal diagnosticians, obstetricians, and anesthesiologists with optimal care in a specialized center, the otherwise high morbidity/mortality can be minimized.
Identifiants
pubmed: 36766644
pii: diagnostics13030539
doi: 10.3390/diagnostics13030539
pmc: PMC9914632
pii:
doi:
Types de publication
Journal Article
Langues
eng
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Arch Gynecol Obstet. 2018 May;297(5):1151-1156
pubmed: 29404741
Cureus. 2021 Oct 17;13(10):e18842
pubmed: 34804697
Arch Gynecol Obstet. 2022 Jan;305(1):291-292
pubmed: 35018516
Int J Gynaecol Obstet. 2023 Mar;160(3):955-961
pubmed: 35964250
Ultraschall Med. 2020 Apr;41(2):120-137
pubmed: 32259863
Obstet Gynecol. 2018 Dec;132(6):e259-e275
pubmed: 30461695